Alternatively, a letter such as this can be sent to patients in a packet with the notification letter for them to take with them to their primary healthcare provider. Sending a letter such as this (to the patients’ primary healthcare providers and to all area healthcare providers and laboratories) can help assure that the correct testing is provided to all patients. When testing is being recommended, options for testing typically include the facility where the incident occurred, the patients’ individual healthcare providers, an independent laboratory, or the health department. This sample courtesy letter is intended for the patients’ primary healthcare provider to inform him/her that the patient is receiving a notification letter, as well as which tests are recommended for the patient. Sample Primary Healthcare Provider Notification of Testing Recommendations Letter This sample letter was issued by a health department when disease transmission resulting from an infection control breach was identified. Sample Patient Letter B: Disease Transmission Identified.This sample letter was issued by a healthcare facility when an infection control breach was recognized but no disease transmission had yet been identified. Sample Patient Letter A: No Disease Transmission Identifiedĭownload Customizable letter word icon.Here we are including two sample letters with the following parameters: Patient notification letters can vary based on who is issuing them (a health department or a healthcare facility in coordination with a health department), whether just an infection control lapse or actual disease transmission has been identified, and whether or not testing is being recommended. Additionally, links to fact sheets on bloodborne pathogens (e.g., hepatitis B, hepatitis C, and HIV) and injection safety are included. This section offers sample notification letters, a summary of formative research on patient notification conducted by CDC, and resources on risk communications. CDC is available to assist with the process of developing documents for a patient notification. Other materials (e.g., testing recommendations letter, test results letter) may or may not be needed depending on whether testing is being recommended by the public health authorities who are conducting the investigation. Most often letters are used to quickly deliver a consistent message to all patients, using certified mail or other traceable shipping service to verify delivery. Personnel who are responsible for making the calls must be comfortable with the script they will use to deliver the message and have the ability to answer any immediate questions the patients may have. Patient notifications can be conducted via phone call if the number of patients being notified is small. Advisories were issued to Physician Office Clinical Laboratories and Clinical Laboratories/Limited Service Laboratories.A patient notification almost always involves a letter being mailed to each patient who was potentially exposed to bloodborne or other pathogens. Effective April 4, 2022, NYS will be implementing the HHS SARS-CoV-2 laboratory data reporting requirements. In some instances, HHS will no longer require reporting of SARS-CoV-2 test results. Department of Health & Human Services (HHS) and the Centers for Disease Control and Prevention (CDC) announced revisions to HHS SARS-CoV-2 laboratory data reporting requirements that will become effective on April 4, 2022. Packaging & Transport Checklist for proper specimen packaging and transport for testing at a laboratory.Instructions for NYSDOH Wadsworth Center COVID-19 Specimen Collection, Handling and Transport.Specimen Collection, Handling and Transport For sample collectors unable to request tests electronically, the Infectious Diseases Requisition Form must be completed in paper or PDF format.For sample collectors with access to the Health Commerce System, Electronic Test Requests can be used for sample submission.Sample collectors submitting COVID-19 specimens to the Wadsworth Center must use one of the two methods below. Sample collection entities must seek advanced approval by Wadsworth Center prior to sending samples. Wadsworth Center, the NYS Public Health Laboratory, continues to provide COVID-19 testing for select sample collection entities (including but not limited to State agency run congregational settings with vulnerable populations, local health departments, and other entities responding to outbreak investigations). Required Information for Infectious Disease Requisition Letter to physician office laboratories.Letter to pharmacies with Limited Service Laboratories (LSL).Letter regarding patient service centers.Disposal of Unused Expired COVID-19 Rapid Tests.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |